AIDS in Latin America

被引:13
作者
Cahn, P [1 ]
Belloso, WH
Murillo, J
Prada-Trujillo, G
机构
[1] Univ Buenos Aires, Sch Med, Dept Infect Dis, RA-1053 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Med, Dept Pharmacol, RA-1053 Buenos Aires, DF, Argentina
[3] Juan Fernandez Hosp, Dept Infect Dis, Buenos Aires, DF, Argentina
[4] Huesped Fdn, Buenos Aires, DF, Argentina
[5] Hosp Italiano Buenos Aires, Infect Dis Sect, Buenos Aires, DF, Argentina
[6] Ctr Med Caracas, Dept Infect Dis, Caracas, Venezuela
[7] Cent Univ Venezuela, Hosp Vargas Caracas, Dept Infect Dis, Caracas, Venezuela
[8] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Unidad Infectiol, Bogota, Colombia
关键词
D O I
10.1016/S0891-5520(05)70224-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The HIV-AIDS epidemic in Latin America has produced an unexpected additional burden to health care systems and national economies already weak and affected by severe problems. Specific regional diseases, such as Chagas' disease, leishmaniasis, and histoplasmosis, in addition to common opportunistic infections, and particularly the high incidence of tuberculosis, produce a slightly different epidemiologic picture compared with the United States and Europe. Access to antiretrovirals is not universal in Latin America. Nevertheless, some countries are providing highly active antiretroviral therapy to all eligible patients, showing that it is not impossible to improve the quality of care for people living with AIDS in the region. Drug interactions between antiretrovirals and specific treatments for regional diseases generate additional concerns for the already complex picture of the HIV-AIDS epidemic in the region.
引用
收藏
页码:185 / +
页数:26
相关论文
共 152 条
[1]  
ALSIP S, 1980, CURR CLIN TOP INFECT, V7, P254
[2]   LEISHMANIASIS AND AIDS COINFECTION - THE SPANISH EXAMPLE [J].
ALVAR, J .
PARASITOLOGY TODAY, 1994, 10 (04) :160-163
[3]   Leishmania and human immunodeficiency virus coinfection: The first 10 years [J].
Alvar, J ;
Canavate, C ;
GutierrezSolar, B ;
Jimenez, M ;
Laguna, F ;
LopezVelez, R ;
Molina, R ;
Moreno, J .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :298-+
[4]  
ARIZA D, 1999, PAN AM C INF DIS GUA
[5]  
ASTARLOA L, 1992, 8 INT C AIDS AMST NE
[6]   RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR REVERSES NEUTROPENIA AND REDUCES SECONDARY INFECTIONS IN VISCERAL LEISHMANIASIS [J].
BADARO, R ;
NASCIMENTO, C ;
CARVALHO, JS ;
BADARO, F ;
RUSSO, D ;
HO, JL ;
REED, SG ;
JOHNSON, WD ;
JONES, TC .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :413-418
[7]  
BADARO R, 1996, LEISHMANIOSE, V7, P150
[8]   Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations [J].
Barry, M ;
Gibbons, S ;
Back, D ;
Mulcahy, F .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :194-209
[9]   EPIDEMIOLOGIC CHARACTERISTICS OF 105 CASES OF CRYPTOCOCCOSIS DIAGNOSED IN ARGENTINA, BETWEEN 1981-1990 [J].
BAVA, AJ ;
NEGRONI, R .
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 1992, 34 (04) :335-340
[10]  
Bava Amadeo J., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P531, DOI 10.1590/S0036-46651995000600010